6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
12m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
44m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
44m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
44m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
45m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Nunzia Pharmaceutical Corporation (PINK:NUNZ) — investor relations, events, news, and company updates on 6ix.

Latest News

Nunzia Pharmaceutical Corporation (OTC: NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Now Offering a Patented Blood Warmer Through Nunzia's Medical Supply Division. 8K Filed 08/05/2021

Nunzia Pharmaceutical Corporation (OTC:NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, has Signed a Licensing Agreement with Michael Mitsunaga for the Exclusive Patent Rights to his IV BLOOD WARMER

Nunzia Pharmaceutical Corporation, an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Proud to Start Studies on Anxiety-Based Tinnitus

Nunzia Pharmaceutical Corporation is an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals

Cancelling S8 Shares

Financials

Revenue

$0

Market Cap

$43.45 K

EPS

-0.01

Community Chat

Ask AI